WallStreetZenWallStreetZen
Analyst Ranking
Bottom 12%
#4073 out of 4571 analysts
Average Return
-3.52%
Win Rate
48%12 out of 25
Risk vs Reward
Poor
Good

Matt Hewitt's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Simulations Plus IncSLP
+142.31%$31.01$75.14
2020-01-05 -
2021-01-06
Buy
Avid Bioservices IncCDMO
+64.44%$4.64$7.63
2023-12-07 -
2024-04-30
Buy
Ligand Pharmaceuticals IncLGND
+63.13%$80.55$131.40
2020-10-20 -
2021-10-20
Buy
Inotiv IncNOTV
+50.59%$2.55$3.84
2023-12-11 -
2024-04-30
Buy
Biolife Solutions IncBLFS
+41.22%$12.42$17.54
2023-08-09 -
2024-04-30
Buy

Matt Hewitt Analyst Color

Get additional color on Matt Hewitt's coverage of popular stocks

Matt Hewitt's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Schrodinger IncSDGR
2Buy$35.00+43.56%Maintains
3 months ago
Simulations Plus IncSLP
5Buy$51.00+12.46%Maintains
4 months ago
Agiliti IncAGTI
1Buy$23.00+126.60%Initiates Coverage On
4 months ago
Inotiv IncNOTV
2Buy$25.00+551.04%Maintains
5 months ago
Avid Bioservices IncCDMO
3Buy$16.00+109.70%Maintains
5 months ago
Maxcyte IncMXCT
1Buy$7.00+92.84%Initiates Coverage On
5 months ago
Biolife Solutions IncBLFS
2Buy$23.00+31.13%Maintains
9 months ago
Repligen CorpRGEN
2Buy$200.00+21.80%Maintains
9 months ago
Omniab IncOABI
1Buy$10.00N/AInitiates Coverage On
a year ago
Surgalign Holdings IncSRGAQ
2Hold$2.00N/AMaintains
a year ago
Science 37 Holdings IncSNCE
1Buy$200.00N/AInitiates Coverage On
2 years ago
Cynergistek IncCTEK
1Hold$1.25N/ADowngrades
2 years ago
Teladoc Health IncTDOC
4Hold$30.00N/AMaintains
2 years ago
Ispecimen IncISPC
1Buy$20.00N/AInitiates Coverage On
2 years ago
Omnicell IncOMCL
1Buy$205.00N/AMaintains
2 years ago
Ligand Pharmaceuticals IncLGND
1Buy$195.00N/AMaintains
4 years ago
Vocera Communications IncVCRA
1Buy$30.00N/AUpgrades
4 years ago
Apollo Endosurgery IncAPEN
1Buy$11.00N/AInitiates Coverage On
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.